Myeloma Institute for Research & Therapy Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2004
NCT00090493
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2004

Timeline

NOW
  • Now